Oxford Biomedica annual net debt
2020
2021
2022
2023
2024
2025
Oxford Biomedica Net Debt Growth & History (OXB)
Oxford Biomedica's net debt was £51.2M for fiscal 2025.
View full Oxford Biomedica company overviewOxford Biomedica annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | £51.2M | £3.1M | +6.51% |
| 2024 | 2024-12-31 | £48.1M | £40.4M | +521.43% |
| 2023 | 2023-12-31 | £7.7M | £34.7M | — |
| 2022 | 2022-12-31 | −£27.0M | £72.6M | — |
| 2021 | 2021-12-31 | −£99.6M | −£66.7M | — |
| 2020 | 2020-12-31 | −£32.9M | — | — |
Oxford Biomedica quarterly net debt
Q4.24
Q2.25
Q4.25
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | £51.2M | £3.1M | +6.51% |
| Q2 2025 | 2025-06-30 | £51.5M | — | — |
| Q4 2024 | 2024-12-31 | £48.1M | — | — |
Oxford Biomedica net debt trends
Over the last five fiscal years, Oxford Biomedica's net debt increased from −£32.9M to £51.2M, a change of £84.1M. The latest reported quarter, Q4 2025, shows £51.2M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Oxford Biomedica source filings ↗